In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Procalcitonin (PCT) Tests are carried out to diagnose and monitor sepsis, by measuring the production of PCT, a peptide precursor of the hormone calcitonin, which increases in response to a pro-inflammatory stimulus, typically as a result of bacterial infection. GlobalData uses proprietary data and analytics to provide a comprehensive report on the procalcitonin tests devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the procalcitonin tests market in Australia was F. Hoffmann-La Roche followed by bioMerieux, Abbott Laboratories, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, Quidelortho and DiaSorin.
This includes Procalcitonin Enzyme Immunoassay Tests and Procalcitonin Other Tests which use alternative technologies, such as Fluorescence Immunoassay, latex-enhanced Immunoturbidimetric assay, and Lateral Flow immunochromatographic test strips.
The value of the procalcitonin tests devices market within Australia was expected to be over $30m in 2023.
For the latest complete market share analysis of procalcitonin tests device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
